BSECompany Update2d ago · 5 Nov 2026, 01:25 pm
Please find attached intimation regarding ESG Rating
Mankind Pharma Ltd · 543904
✦ AI SummaryESG
Mankind Pharma Ltd has been assigned an ESG rating of 64.8 by SES ESG Research Private Limited, a SEBI registered ESG rating provider, for FY26 based on publicly available information.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Ltd - 543904 - Intimation Regarding ESG Rating
Attachments (1)
📄pdf
Download →
9650eb76-ab33-449d-b193-d822f5a21f6c.pdf
View document text
November 5, 2026
BSE Limited National Stock Exchange of India Limited
P J Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Bandra Kurla Complex,
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 543904 Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Environmental, Social and Governance (ESG) Rating
Ref.: Regulation 30 & 51 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (“Listing
Regulations”)
With reference to the captioned subject, we wish to inform you SES ESG Research Private
Limited (“SES”), a SEBI registered ESG Rating Provider, has assigned the Environmental,
Social, and Governance (ESG) Rating of ‘64.8’ to the Company.
The Company has not engaged SES for the said rating, same has been independently assigned
by SES for FY26, based on publicly available information.
The above disclosure is also being made available on the Company’s website at
www.mankindpharma.com.
This is for your information and records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer